Correlation
The correlation between GMED and JNJ is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
GMED vs. JNJ
Compare and contrast key facts about Globus Medical, Inc. (GMED) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GMED or JNJ.
Performance
GMED vs. JNJ - Performance Comparison
Loading data...
Key characteristics
GMED:
-0.30
JNJ:
0.55
GMED:
-0.10
JNJ:
0.89
GMED:
0.98
JNJ:
1.12
GMED:
-0.24
JNJ:
0.64
GMED:
-0.70
JNJ:
1.68
GMED:
13.70%
JNJ:
6.54%
GMED:
36.91%
JNJ:
18.83%
GMED:
-47.91%
JNJ:
-52.60%
GMED:
-36.58%
JNJ:
-8.05%
Fundamentals
GMED:
$8.02B
JNJ:
$369.52B
GMED:
$1.33
JNJ:
$8.98
GMED:
44.28
JNJ:
17.10
GMED:
1.70
JNJ:
1.04
GMED:
3.19
JNJ:
4.14
GMED:
1.95
JNJ:
4.73
GMED:
$2.51B
JNJ:
$89.33B
GMED:
$1.43B
JNJ:
$61.01B
GMED:
$486.48M
JNJ:
$34.70B
Returns By Period
In the year-to-date period, GMED achieves a -28.45% return, which is significantly lower than JNJ's 9.11% return. Over the past 10 years, GMED has outperformed JNJ with an annualized return of 8.80%, while JNJ has yielded a comparatively lower 7.44% annualized return.
GMED
-28.45%
-17.54%
-30.87%
-11.13%
-3.86%
1.61%
8.80%
JNJ
9.11%
0.15%
1.79%
10.31%
-1.81%
3.76%
7.44%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GMED vs. JNJ — Risk-Adjusted Performance Rank
GMED
JNJ
GMED vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GMED vs. JNJ - Dividend Comparison
GMED has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 3.23%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 3.23% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
GMED vs. JNJ - Drawdown Comparison
The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for GMED and JNJ.
Loading data...
Volatility
GMED vs. JNJ - Volatility Comparison
Globus Medical, Inc. (GMED) has a higher volatility of 28.22% compared to Johnson & Johnson (JNJ) at 6.09%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GMED vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Globus Medical, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GMED vs. JNJ - Profitability Comparison
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported a gross profit of 402.72M and revenue of 598.12M. Therefore, the gross margin over that period was 67.3%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported an operating income of 97.00M and revenue of 598.12M, resulting in an operating margin of 16.2%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported a net income of 75.46M and revenue of 598.12M, resulting in a net margin of 12.6%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.